- Iron chelation by deferoxamine in sickle cell patients with severe transfusion-induced hemosiderosis: a randomized, double-blind study of the dose-response relationship. Silliman, C.C., Peterson, V.M., Mellman, D.L., Dixon, D.J., Hambidge, K.M., Lane, P.A. J. Lab. Clin. Med. (1993)